Marker Therapeutics, Inc.

Q1 2026 13F Holders

Symbol
MRKR
CUSIP
57055L206
Type
Equity
Class
COM NEW
Num filings
35
Total reported value, excl. options
$5.07 M
Manager Report Date Value ($000) Shares Option Type